Stocksigma LogoStocksigma Logo

Cipla Subsidiary InvaGen Receives Zero USFDA Observations for New York Facility

The USFDA conducted a routine current Good Manufacturing Practices (cGMP) inspection at the Hauppauge, Long Island, New York facility of Cipla's wholly

Cipla Subsidiary InvaGen Receives Zero USFDA Observations for New York Facility

Cipla Ltd 路 Others (Uncategorized) 路 23 Oct 2026, 2:32 pm

Cipla Subsidiary InvaGen Receives Zero USFDA Observations for New York Facility The USFDA conducted a routine current Good Manufacturing Practices (cGMP) inspection at the Hauppauge, Long Island, New York facility of Cipla's wholly owned subsidiary, InvaGen Pharmaceuticals Inc., from 19th Oct'26 to 22nd Oct'26. The inspection concluded successfully with zero Form 483 observations, confirming full regulatory compliance for the manufacturing site.

Original exchange filing (PDF)

More announcements from Cipla Ltd

All Cipla Ltd announcements